| Printed covalent glycan array for ligand profiling of diverse glycan binding proteins O Blixt, S Head, T Mondala, C Scanlan, ME Huflejt, R Alvarez, MC Bryan, ... Proceedings of the National Academy of Sciences 101 (49), 17033-17038, 2004 | 1303 | 2004 |
| Antibody domain exchange is an immunological solution to carbohydrate cluster recognition DA Calarese, CN Scanlan, MB Zwick, S Deechongkit, Y Mimura, R Kunert, ... Science 300 (5628), 2065-2071, 2003 | 998 | 2003 |
| Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12 DA Calarese, HK Lee, CY Huang, MD Best, RD Astronomo, RL Stanfield, ... Proceedings of the National Academy of Sciences 102 (38), 13372-13377, 2005 | 396 | 2005 |
| Covalent display of oligosaccharide arrays in microtiter plates MC Bryan, F Fazio, HK Lee, CY Huang, A Chang, MD Best, DA Calarese, ... Journal of the American Chemical Society 126 (28), 8640-8641, 2004 | 232 | 2004 |
| Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation WI Tsou, KQN Nguyen, DA Calarese, SJ Garforth, AL Antes, SV Smirnov, ... Journal of Biological Chemistry 289 (37), 25750-25763, 2014 | 217 | 2014 |
| Reactivity‐based one‐pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti‐HIV‐1 antibody HK Lee, CN Scanlan, CY Huang, AY Chang, DA Calarese, RA Dwek, ... Angewandte Chemie International Edition 43 (8), 1000-1003, 2004 | 185 | 2004 |
| Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity KQN Nguyen, WI Tsou, DA Calarese, SG Kimani, S Singh, S Hsieh, Y Liu, ... Journal of Biological Chemistry 289 (37), 25737-25749, 2014 | 92 | 2014 |
| The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12 CN Scanlan, R Pantophlet, MR Wormald, EO Saphire, D Calarese, ... Glycobiology and Medicine, 205-218, 2003 | 72 | 2003 |
| A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120 A Menendez, DA Calarese, RL Stanfield, KC Chow, CN Scanlan, ... The FASEB journal: official publication of the Federation of American …, 2008 | 44 | 2008 |
| Inhibition of zinc-dependent histone deacetylases with a chemically triggered electrophile ZV Boskovic, MM Kemp, AM Freedy, VS Viswanathan, MS Pop, JH Fuller, ... ACS Chemical Biology 11 (7), 1844-1851, 2016 | 27 | 2016 |
| Ian. A. Wilson, and Chi-Huey Wong HK Lee, CN Scanlan, CY Huang, AY Chang, DA Calarese, RA Dwek, ... Angew. Chem. Int. Ed 116, 1018-1018, 2004 | 13 | 2004 |
| Discovery of STRO-002, a novel homogeneous ADC targeting folate receptor alpha, for the treatment of ovarian and endometrial cancers X Li, S Zhou, CL Abrahams, S Krimm, J Smith, K Bajjuri, HT Stephenson, ... Molecular Cancer Therapeutics 22 (2), 155-167, 2023 | 12 | 2023 |
| Toward a carbohydrate-based HIV-1 vaccine L Kong, JP Julien, D Calarese, C Scanlan, HK Lee, P Rudd, CH Wong, ... Glycobiology and drug design, 187-215, 2012 | 9 | 2012 |
| Domain-exchanged binding molecules, methods of use and methods of production D Calarese, D Burton, I Wilson US Patent App. 10/838,153, 2005 | 6 | 2005 |
| Antibody recognition of a carbohydrate epitope: a template for HIV vaccine design C Scanlan, D Calarese, HK Lee, O Blixt, CH Wong, I Wilson, D Burton, ... Glycobiology and Medicine: Proceedings of the 7th Jenner Glycobiology and …, 2005 | 6 | 2005 |
| Toward a carbohydrate-based HIV-1 vaccine D Calarese, C Scanlan, HK Lee, P Rudd, CH Wong, R Dwek, D Burton, ... | 4 | 2006 |
| Antibodies with engineered CH2 domains, compositions thereof and methods of using the same D Calarese, G Yin US Patent 11,098,107, 2021 | 1 | 2021 |
| Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates A Gakhal, YU Abigail, R Stafford, J Hanson, A Yam, K Bajjuri, A Maderna, ... US Patent App. 18/345,892, 2024 | | 2024 |
| Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates A Gakhal, YU Abigail, R Stafford, J Hanson, A Yam, K Bajjuri, A Maderna, ... US Patent App. 18/349,337, 2024 | | 2024 |
| Antibodies with engineered ch2 domains, compositions thereof and methods of using the same D Calarese, G Yin US Patent App. 18/357,966, 2024 | | 2024 |
